317 related articles for article (PubMed ID: 30422775)
1. Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
Kandathil A; Kay FU; Butt YM; Wachsmann JW; Subramaniam RM
Radiographics; 2018; 38(7):2134-2149. PubMed ID: 30422775
[TBL] [Abstract][Full Text] [Related]
2. Staging Lung Cancer: Metastasis.
Shroff GS; Viswanathan C; Carter BW; Benveniste MF; Truong MT; Sabloff BS
Radiol Clin North Am; 2018 May; 56(3):411-418. PubMed ID: 29622076
[TBL] [Abstract][Full Text] [Related]
3. An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Finkle JH; Penney BC; Pu Y
Lung Cancer; 2018 Sep; 123():136-141. PubMed ID: 30089584
[TBL] [Abstract][Full Text] [Related]
4. Dilemmas in Lung Cancer Staging.
Vlahos I
Radiol Clin North Am; 2018 May; 56(3):419-435. PubMed ID: 29622077
[TBL] [Abstract][Full Text] [Related]
5. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer.
Hattori A; Takamochi K; Oh S; Suzuki K
Jpn J Clin Oncol; 2019 Jan; 49(1):3-11. PubMed ID: 30277521
[TBL] [Abstract][Full Text] [Related]
6. Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.
Sakai K; Kuramoto J; Kojima A; Nishimura H; Kuwabara Y; Toda M; Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Mikami S; Kyoyama H; Moriyama G; Gemma A; Uematsu K
Int J Clin Oncol; 2019 Dec; 24(12):1549-1557. PubMed ID: 31452019
[TBL] [Abstract][Full Text] [Related]
7. M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome.
Park H; Dahlberg SE; Lydon CA; Araki T; Hatabu H; Rabin MS; Johnson BE; Nishino M
Oncologist; 2019 Aug; 24(8):e749-e754. PubMed ID: 30696724
[TBL] [Abstract][Full Text] [Related]
8. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations.
Feng SH; Yang ST
Diagn Interv Radiol; 2019 Jul; 25(4):270-279. PubMed ID: 31295144
[TBL] [Abstract][Full Text] [Related]
9. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.
Nicholson AG; Chansky K; Crowley J; Beyruti R; Kubota K; Turrisi A; Eberhardt WE; van Meerbeeck J; Rami-Porta R; ;
J Thorac Oncol; 2016 Mar; 11(3):300-11. PubMed ID: 26723244
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.
Shin J; Keam B; Kim M; Park YS; Kim TM; Kim DW; Kim YW; Heo DS
J Thorac Oncol; 2017 Mar; 12(3):520-528. PubMed ID: 27867003
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
Kandathil A; Subramaniam RM
Semin Nucl Med; 2022 Nov; 52(6):650-661. PubMed ID: 35738910
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
14. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
[TBL] [Abstract][Full Text] [Related]
15. Metabolic tumor burden quantified on [
Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
Chen K; Chen H; Yang F; Sui X; Li X; Wang J
Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
Tufman A; Kahnert K; Kauffmann-Guerrero D; Manapov F; Milger K; Müller-Lisse U; Winter H; Huber RM; Schneider C
Strahlenther Onkol; 2017 May; 193(5):392-401. PubMed ID: 28246699
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
19. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
[TBL] [Abstract][Full Text] [Related]
20. Staging of Non-Small-Cell Lung Cancer.
Akhurst T
PET Clin; 2018 Jan; 13(1):1-10. PubMed ID: 29157380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]